Q4 2025 Earnings Call February 10, 2026 6:45 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal ...

Detailed price information for Vtv Theraptcs Cl A (VTVT-Q) from The Globe and Mail including charting and trades.

Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia February 12, 2026 8:00 ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that IP ...

Dr. Hsiang's decades of leadership, integrity, and lived experience within Canada's healthcare institutions uniquely position him to translate these principles into operational clinics, governance ...

The most influential names this year aren’t simply offering strategies — they’re reshaping how individuals think, heal, earn, ...

Dementia care isn't just about new drugs, said the author of a cost-effectiveness study comparing collaborative care, Leqembi ...

FEBRUARY 2026 at 12:00 EET Orion Group Financial Statement Release January-December 2025 October-December 2025 Highlights Net sales totalled ...

Tired of a branding workshop that feels like pricey therapy? Stop wasting money. Learn how our data-driven strategy sessions ...

The outlook for 2026 (provided on 14 January 2026): Net sales are estimated to be EUR 1,900 million to EUR 2,100 million. Operating profit is estimated to be EUR 550 million to EUR 750 million. Basic ...

Collaborative Alzheimer’s care improved quality of life and saved billions when scaled nationwide, outperforming the antiamyloid drug lecanemab, results of a new cost analysis suggest.

For some people, receiving therapy more frequently over a shorter period can lead to faster relief, better engagement, and ...